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Objectives: The aim of this study is to investigate the effects of ovariectomy on bone mineral density (BMD)
and oxidative state in rats, and the alterations in these effects that vitamin C supplementation may produce.
Materials and methods: Twenty female Wistar albino rats were randomly divided into three groups: control
(C, n6); ovariectomy (O, n7); and ovariectomyvitamin C supplement (OV, n7). Oxidative stress (OS)
was assessed 100 days postovariectomy by measuring the activity of several enzymes, including catalase
(CAT), superoxide dismutase (SOD), and glutathione peroxidase, as well as the concentrations of
malondialdehyde (MDA), nitric oxide (NO), and total sulfhydryl groups in plasma and bone homogenates.
Results: A significant decrease in BMD was observed in O group compared with C group (p0.015), and a
significant increase was observed in OV compared with O group (p0.003). When groups were compared
with respect to parameters of OS, MDA and NO levels in bone tissue were significantly higher in O than in C
(p0.032, p0.022) and were significantly lower in OV than in O (p0.025, p0.018). SOD activity was
significantly higher in O than in C (p0.032). In plasma, MDA activity was significantly higher in O than in
C( p0.022) and NO level was significantly higher in O than in C and OV (p0.017, p0.018).
Conclusions: Our results suggest that ovariectomy may produce osteoporosis and OS in females, and vitamin
C supplementation may provide alterations regarding improvement in OS and BMD values. We assume that
studies including more subjects are needed to make a decisive conclusion about OSBMD relation.
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O
steoporosis (OP) is a disease characterized by low
bone mass without alteration in bone composi-
tion, which leads to increased risk of fracture.
Being most common in women after menopause, the
ovariectomized rats are used specifically as the animal
model to observe the effects of OP since the biological
mechanisms related with bone resorption in ovariecto-
mized rats highly resemble to the postmenopausal bone
loss in women (1, 2). A close relation was observed
between increased bone turnover and OP formation at
early and late periods after ovariectomy in rats (3).
Oxidative stress (OS) is a state of imbalance in favor of
pro-oxidants versus antioxidants, resulting in cellular
damage that is often irreversible (4, 5) and can be
observed in diseases such as OP, respiratory distress
syndrome, atherosclerosis, chronic renal failure, rheuma-
toid arthritis, diabetes, sepsis, and Alzheimer’s disease.
OS can be evaluated by determining the levels of
antioxidants, such as superoxide dismutase (SOD), glu-
tathione peroxidase (GPx), glutathione-S-transferase,
catalase (CAT), and glutathione reductase, that inhibit
the detrimental effects of reactive oxygen species (ROS)
and free radicals by determining the thiobarbituric acid
reactive substance and nitric oxide synthetase (NOS)
levels in aerobic organisms (46).
Although estradiol is known to function as an
antioxidant and as a free radical scavenger, the under-
lying mechanism remains obscure. It is reported that OS
is increased and some antioxidants are decreased (6, 7) or
increased (8, 9) in relation to menopause in which
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ship between OS and the decrease in bone mineral density
(BMD) (10). These findings suggest that OS may play a
role in the pathology of postmenopausal OP and that
supplementation with antioxidants may be beneficial in
the treatment of this condition.
Vitamin C, a potent antioxidant, was shown to
decrease bone resorption in laboratory studies. The
mechanism by which vitamin C (ascorbic acid) exerts
effect on bone density is unclear, but it may be related to
its effects on collagen formation and osteoblast develop-
ment or to the increase in calcium absorption (11, 12).
Interesting results have been reported in studies
evaluating the role of oxidants and antioxidants in OP
(69). There are only a few studies available that reported
the effect of vitamin C treatment on BMD (13). There-
fore, in the present study, we evaluated the relation
between OS and OP in ovariectomized rats. We measured
plasma and femur bone tissue levels of nitric oxide (NO),
total sulfhydryl (t-SH), malondialdehyde (MDA), SOD,
CAT, and GPx. We also evaluated the effects of vitamin
C supplementation on the parameters of OS and bone
density.
Materials and methods
Twenty female Wistar albino rats raised in the same
environment and weighing 175215 g were used in this
study (14). They were maintained in a well-ventilated
controlled room at 20228C on a 12-h light/12-h dark
schedule. The study protocol was approved by the
Institutional Ethical Committee. The rats were randomly
divided into three groups: control group (C, n 6),
ovariectomy group (O, n7), and ovariectomyvitamin
C group (OV, n7). The rats had access to food and
water until 2 h prior to the anesthesia.
After anesthesia (intraperitoneal ketamine, 50 mg/kg),
bilateral ovariectomy was performed with a ventral
approach. Surgical procedure was not performed to
the control group. After surgical procedure, vitamin C
(L-ascorbic acid) was added to the drinking water of the
OV group at a concentration of 1 g/500 ml water. Aperiod
of 100 days was allowed for the development of OP (3, 4).
BMD measurements
Bone mineral densities of all rats were measured 100 days
after ovariectomy prior to euthanasia, using dual-energy
X-ray absorptiometry (Norland XR-36; Norland Inc.,
Fort Atkinson, WI) with small subjects’ program (11
mm resolution, 60 mm/s sweep speed). BMD was
determined as the amount of mineral per cubic centi-
meters of bone (g/cm
3).
Biochemical measurements
Anesthesia was performed with intraperitoneal injection
of ketamine (50 mg/kg), and 5 ml blood sample was
collectedfromintra-abdominalregionpriortoeuthanasia.
Blood samples with ethylenediaminetetraacetic acid
were centrifuged and the plasma was stored at 808C
together with bone samples until analyzed. Bone samples
were homogenized in the 0.1 M phosphate buffer. The
homogenates were centrifuged and the supernatant was
used for analysis. To assess OS, the levels of CAT, SOD,
GPx, MDA, NO, and t-SH were measured both in
plasma and bone homogenates.
Cayman (Ann Arbor, MI) kits were used in CAT
analysis and Randox (Crumlin, UK) kits in SOD and
GPx analysis. All samples were analyzed in the labora-
tories of the Biochemistry Department.
Statistical analysis
Statistical Package for the Social Sciences (Chicago, IL)
v12.0 program was used for statistical analysis. Descrip-
tive statistics were conducted on all variables. Variations
in bone and plasma oxidative state parameters between
study groups were assessed by using KruskalWallis test.
Bonferroni-adjusted MannWhitney U test was used
after significant KruskalWallis to determine which
group differs from the other. Spearman’s rank correlation
test was used to determine the relation between BMD
and oxidative state parameters. Results were expressed as
mean9standard deviation (Mean9SD) and minimum
maximum (minmax). Statistical significance was set at
pB0.05 for all analysis and pB0.033 (0.1/3) for Bonfer-
roni-adjusted MannWhitney U test.
Results
There was no statistically significant difference observed
in body weights of rats at onset and at conclusion of the
study within and between groups (Table 1). A significant
decrease in BMD was observed in O group compared
with C group (p0.015) and a significant increase was
observed in OV compared with O group (p0.003).
BMD values are given in Table 2 and Fig. 1.
When groups were compared regarding oxidant and
antioxidant parameters, MDA levels in bone tissue were
significantly higher in group O than in C and OV (p
0.032 and p0.025, respectively). There was no differ-
ence between groups C and OV. NO levels were sig-
nificantly higher in group O than in either group C or
group OV (p0.022, p0.018, respectively). There was
no difference between groups C and OV. SOD activity
was significantly higher in group O than in group C (p
0.032). There were no statistically significant differences
in bone t-SH, CAT, and GPx levels (Table 3).
The plasma MDA activity was significantly higher in
O than in C (p0.022); NO level was significantly
higher in O than in C or OV (p0.017, p0.018,
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ference in plasma t-SH, SOD, CAT, and GPx levels
(Table 4). No correlation was observed between BMD
and the measured parameters of OS.
Discussion
This study revealed that BMD was significantly reduced
in ovariectomized rats and that vitamin C supplement
restored BMD to control levels. OS was induced in bone
and plasma with ovariectomy and levels of antioxidants
raised in response to decrease in OS. Vitamin C supple-
ment was also shown to reduce OS. No correlation was
found between BMD and pro-oxidant and antioxidant
parameters.
OP is generally accepted as the pathological condition
due to aging. Also, OS is intimately connected to the
process of aging. The relation between OP and OS has
been examined in many studies. It is suggested that by
reducing or eliminating OS, the loss of BMD and OP
could be prevented (10).
There is an increase in superoxide formation by the
osteoclasts that accompanies active bone resorption and
loss of bone density (14).
It is considered that oxidative state is important in OP
and coherent with the relation between diseases like
OP and arteriosclerosis in which OS plays a major role. In
addition, it is stated that OS and BMD are correlated in
women (urine 8-iso-P6F2 levels indicates OS) (7, 15).
Recently, in vitro or animal studies showed that OS has
an important role in osteoclast differentiation and
functions. On the other hand, it was indicated that ROS
plays an important role in osteoblastic functions (16).
In vivo and in vitro studies proved that NO (NO is a
free radical that causes OS) plays a role in osteoblastic
and osteoclastic activities (8, 15).
Animal and human studies showed that NO is an
important regulator in bone metabolism (17, 18). But the
outcomes of these experimental results are debated and
the roles of the mechanisms are unclear. It is known that
bone cell produces NO as a response of estrogens,
proinflammatory cytokines, and mechanic stress, during
this process different NOS isoforms take part (17, 19).
Van’t Hof et al. (19) noticed that neuronal NOS (nNOS)
in knockout rats plays a role on increased bone mass
regulation and bone circle. Caballero et al. (18) empha-
sized a similar result in their study. Contrast to this result,
Baecker et al. (20) reported that, in early postmenopause,
L-arginine treatment (natural NO percussor) is not
effective in bone resorption or in bone formation.
The relationship between NO and BMD is controver-
sial. Aguirre (21) advocated that resection of NO gene in
guinea pigs decreased bone volume, bone formation rate,
and mineral density, whereas Wimalawansa (22) found
that NO donors are protected from postmenopause bone
loss.
Ozgocmen et al. (8) found a significant relationship
between erythrocyte NO and proximal femur BMD rats,
but not with lumbar BMD. In addition, compared with
non-porotic controls, females with postmenopausal OP
have an increased NO level, but they found no difference
Table 1. Comparison of body weights at the beginning and end of treatment period
Weight (g)
C( n6); Mean9SD
(minmax)
O( n7); Mean9SD
(minmax)
OV (n7); Mean9SD
(minmax) p* C-O (p**) C-OV (p**) O-OV (p**)
Beginning 182.596.7 (177195) 183.7910.5 (175203) 182.597.3 (175194) 0.960 0.829 0.829 0.846
End 206.795.1 (200210) 214.3912.7 (200230) 199.3911.7 (175210) 0.092 0.285 0.153 0.051
C: Control, O: Ovariectomy, OV: Ovariectomy vitamin C
Mean9SD: Mean9 standard deviation, minmax: minimummaximum
*Statistical significance was set at pB 0.05 with KruskalWallis test
**Statistical significance was set at pB 0.033 with Bonferroni-adjusted MannWhitney U test
Table 2. Comparison of bone mineral densities
C( n6) Mean9SD
(minmax)
O( n7) Mean9SD
(minmax)
OV (n7) Mean9SD
(minmax) p* C-O (p**) C-OV (p**) O-OV (p**)
Vertebrae
(g/cm
2)
0.12090.007
(0.1160.133)
0.11390.003
(0.1090.118)
0.12190.004
(0.1140.125)
0.004 0.015 0.253 0.003
C: Control, O: Ovariectomy, OV: Ovariectomy vitamin C
Mean9SD: Mean9 standard deviation, minmax: minimummaximum
*Statistical significance was set at pB 0.05 with KruskalWallis test
**Statistical significance was set at pB 0.033 with Bonferroni-adjusted MannWhitney U test
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found increased NO levels in women with OP compared
with non-porotic controls. On comparison between
calcitonin, risedronat, and raloksifen treatment in osteo-
porotic patients, NO level is decreased only in the
risedronat group (23).
Yalin et al. (24) investigated the effect of antioxidants
and free radicals on postmenopausal OP and found that
NO levels in OP patients were higher. In our study, we
found that in the ovariectomized group NO level in femur
bone tissue and plasma was higher than the
ovariectomizedvitamin C group. Although it has been
reported that there was a negative correlation between
NO levels and BMD, we could not find a correlation. We
believe that a correlation could be found if we increase
the number of subjects.
Studies showed that the effect of NO on bone
formation is related to other stimuli, which regulates
the bone formation cycle. In situations with high stress,
like increased osteoblastic activity, NO levels increase in
order to eliminate O2.
 . ONOO
 is a very potent oxidant,
which can affect deoxyribonucleic acid (DNA) and fatty
acids and initiate lipid peroxidation. This mechanism can
explain the increase in NO levels in osteoporotic females.
We believe that our findings support these results.
Many ROS, which are made in cells and tissues, occur
in very low levels. ROS is avery reactive molecule when it
is very high and it affects the defensive systems, causes
tissue damage, and starts lipid peroxidation (25). Lipid
peroxidation is awell-known tissue damage mechanism in
humans and is used in tissue and cells as an OS indicator.
Lipid peroxides are made of polyunsaturated fatty acids;
A BC
BMD (0.1338g/cm2 ) BMD (0.1184 g/cm2 ) BMD (0.1243 g/cm2 )
BMD: Bone Mineral Density 
A (Control), B (Ovariectomy), C (Ovariectomy + Vitamin C) 
Fig. 1. Bone mineral density of lumbar vertebrae.
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compounds. MDA is the biggest group of this compound
and for this reason measuring the level of MDA is the
criteria to understand the lipid peroxidation (26).
Recently it is shown that oxide lipids affect osteoclastic
and osteoblastic bone cells (27).
Levels of the femur hydrogen peroxide (H2O2) and
lipid peroxidation in rats with overectomy indicate the
deficiency of estrogen levels and activate ROS, which
leads to bone loss. H2O2 increases osteoblastic differ-
entiation and function and is necessary for osteoblastic
differentiation as well. It is well known that osteoclasts
express NADPH and produce high levels of ROS during
bone resorption (28).
Ozgocmen et al. (8) showed that increase in MDA
levels (in plasma and erythrocyte) was a result of lipid
peroxidation in osteoporotic females compared with the
non-porotic control group. In another study, Ozgocmen
et al. (23) notified an increase in MDA levels in
osteoporotic females and a decrease in MDA levels in
the group which was treated with calcitonin, risedronat,
and raloksifen. Similarly, Chavan et al. (29) marked the
increase in MDA levels in osteoporotic females, but there
was no change in alkaline phosphatase level.
Although there are studies that investigated the role of
free radicals on bone resorption, Muthusami et al. (6)
noted that the data of the bone loss in ovariectomized
rats are limited and they also found that the levels of
MDA increase, which is induced by lipid per oxidation.
Increased production of H2O2 in femur may cause an
increase in the lipid per oxidation. It was thought that
increased H2O2 induced peroxidation of the polysatu-
rated lipid acids. MDA, which has high reactivation
against the amino groups, inhibits the protein synthesis
and deactivates the enzymes. For this reason, it is
reported that decreased antioxidant enzymes of the femur
corresponded to increased lipid peroxidation.
Basu et al. (10) investigated the lipid peroxidation
levels by assessing the urine levels of the 8-iso-PGF(2a)i n
osteoporotic patients; they indicated that there is a
correlation between lipid peroxidation and BMD.
Experimental and clinical studies about OP point
different results in other findings, except Maggio et al.
(7), besides increased lipid peroxidation and as a result of
this increased MDA activity is indicated (14, 30). In our
study, we found increased MDA activity in femur
compared with other groups and increased MDA activity
in plasma group compared with the control group.
The results of the earlier studies on animals showed
that osteoclastic functions and differentiations are stimu-
lated by the ROS, especially H2O2 and O2
 (6, 15, 16, 28,
31). Oxygen radicals, which appear on cell levels, are
detoxified by the SOD. SOD is inhibited by H2O2, which
is a product of the reaction. Formation of SOD increases
the speed of dismutation by 10
4 times. Consequently, T a b l e
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(page number not for citation purpose)reaction of the radicals with the potential substrates and
formation of hydroxyl, which is a kind of toxic product,
inhibits SOD (32).
Osteoclasts produce high levels of O2
and calciotropic
hormones which stimulate or inhibit the osteoclasts have
also stimulating or inhibiting effect on cell’s production
of anion. H2O2 functions both as intra- and inter-cellular
pulses and has the most appropriate characteristic besides
the other reactive oxygen types. From this point of view,
ROS, which is responsible for bone loss due to estrogen
deficiency, is asserted as H2O2. Increased OS is related
with the risk factors of OP, like smoking, hypertension
(HT), and diabetes mellitus (DM). Estrogen deficiency
decreases the defense of the thiol antioxidants and
induces TNF-a expressions, which result in bone loss (6).
Muthusami et al. (6) indicated increased lipid
peroxidation and H2O2 levels and decreased enzymatic
antioxidants like SOD, GPx, and glutathione-S-
transferase in preovariectomized rats compared with
the control group. They claimed that H2O2 is necessary
for osteoclast differentiation. In another study, the
major intracellular enzyme for H2O2 GPx and its
expression comparing macrophages is amplified and
the levels of enzymes increased by 17-b-eustradiol are
shown (31).
Sontakke and Tare (14) in a group of PMO, renal osteo
dystrophy, and patients with fractured bone have found
decreased GPx and SOD activity compared with the
control group, and this indicates the potential role of
ROS in bone metabolism.
Bednarek-Tupikowska et al. (30) found similar ery-
throcyte SOD results in women with both premenopausal
and postmenopausal OP.
Ozgocmen et al. (8) found that in patients with OS,
SOD enzyme activity was almost same comparedwith the
control group. But on the other hand, osteoporotic
women have high SOD enzyme activity in plasma and
that there was a correlation between erythrocyte SOD
enzyme activity and femur BMD.
Yalin et al. (24), in their study about the role of
antioxidants and free radicals in postmenopausal OP,
reported that SOD activity in patients with OP was
similar compared with the control group. On the other
hand, Chavan et al. (29) showed that serum SOD activity
is notably higher than the control group.
SOD is accepted as the characteristic of antioxidant
defense mechanism. Maggio (7) and Sontakke and Tare
(14) found SOD and GPx levels to be low in the
osteoporotic patients and they believed that as a result
of this the antioxidant defense mechanisms were reduced
in OP.
In our study, like Ozgocmen et al. (8) and Chavan et al.
(29), we found increased SOD activity in the femur bone
tissue in ovariectomized group compared with the control
group. Plasma SOD activities increased in the ovariecto-
mized group, but it was not statistically significant.
Among various studies about the evaluation of GPx,
which is one of the enzymatic antioxidant enzymes,
Maggio et al. (7) reported that plasma GPx activity is
significantly low in osteoporotic patients.
Table 4. Plasma oxidant stress parameters
C( n6);
Mean9SD
(minmax)
O( n7);
Mean9SD
(minmax)
OV (n7);
Mean9SD
(minmax) p*
C-O
(p**)
C-OV
(p**)
O-OV
(p**)
MDA
(nM/ml)
9.2893.36
(6.6115.9)
14.3793.81
(10.8320.96)
11.8893.36
(7.2416.53)
0.044 0.022 0.086 0.277
t-SH
(nM/ml)
0.4290.09
(0.280.56)
0.4490.13
(0.210.63)
0.3890.12
(0.230.58)
0.608 0.668 0.568 0.338
NO
(nM/ml)
46.7596.28
(41.956.5)
82.90930.62
(41.9123.5)
47.0196.33
(37.755.8)
0.020 0.017 0.774 0.018
SOD
(U/ml)
0.5390.08
(0.440.63)
0.7090.18
(0.561.08)
0.5990.14
(0.450.84)
0.105 0.032 0.390 0.250
CAT
(nM/min/ml)
57.5910.3
(39.270.1)
63.8912.2
(42.876.1)
61.1398.23
(53.276.1)
0.511 0.199 0.886 0.522
GPx
(U/L)
2.6190.70
(1.463.28)
3.4590.73
(2.714.93)
2.5791.29
(0.574.02)
0.217 0.073 0.830 0.249
C: Control, O: Ovariectomy, OV: Ovariectomy vitamin C
Mean9SD: Mean9 standard deviation, minmax: minimummaximum
*Statistical significance was set at pB 0.05 with KruskalWallis test
**Statistical significance was set at pB 0.033 with Bonferroni-adjusted MannWhitney U test
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antioxidants decreased, like GPx and glutathione-S-
transferase in ovariectomized rats compared with the
control group and pronounced that H2O2 is necessary for
osteoclast differentiation.
Bednarek-Tupikowska et al. (30) compared premeno-
pausal and postmenopausal women and showed a
significant decrease in erythrocyte GPx activity in post-
menopausal women. Similarly, Sontakke and Tare (14),
in a group of PMO, found decreased GPx activity in
patients with renal dystrophy and bone fracture com-
pared with the control group.
Ozgocmen et al. (8) found similar results in plasma
GPx enzyme activities in OP patients and the control
group. Yalin et al. (24) found reduced GPx activity in
PMO group. The same investigators (9) showed that male
OP patients have significantly low GPx activities, but the
difference is not statistically significant. But in osteo-
porotic patients, compared with the control group, SOD/
GPx was higher. Differences in SOD/GPx ratio are very
important in cellular resistance over cell death and
damage caused by oxidants and also cause increased
ROS formation.
In our study, like Ozgocmen et al. (8) and Yalin et al.
(9), we found that, in femur bone tissue and in plasma,
GPx activity was similar in all the three groups. Causes of
increase in SOD activity and unchanged GPx activity in
ovariectomized group had higher SOD/GPx ratio. We
think that it explains the increase in ROS formation.
Compared with other studies which evaluated another
antioxidant named CAT, Ozgocmen et al. (8) reported
that erythrocyte CATactivity is meaningly low in patients
with postmenopausal OP and also reported that they
found a correlation between erythrocyte CAT enzyme
activity and proximal femur BMD.
In our study, we found that SOD activity was increased
and on the contrary CAT activity was the same in femur
antioxidant defenses. We thought that OS level was not
very high. Catalase, which speeds up the H2O2 formation
with a catalytic reaction transforms H2O2 to two
molecules of water and in this way removes it from the
environment. In our study, the formation speed of H2O2
might not be so high and for that reason we might have
found CAT activities alike.
Plasma thiols are cleaners of the free radicals and in
some instances they can be antioxidant. In pathological
and physiological situations, to evaluate the overproduc-
tion of free radicals, t-SH is measured (33). Protein thiols
in some mechanisms can protect their antioxidant func-
tion; in the beginning of peroxidation they can remove the
antioxidants in a preemptive way (33). We could not find
any study in the literature that evaluated thiol in plasma,
but there are some studies in which the t-SH is measured
(especially in illnesses which are related with OS) (33, 34).
In our study, we found t-SH levels were almost same in
each group. Although femur bone tissue t-SH level in
ovariectomized group decreased from 113.3357.14
(mm/g prt) to 76.042.16 (mm/g prt), this is probably
due to increased standard deviation and low number of
subjects in the study.
A study has shown that vitamin C therapy increases
the t-SH levels (34). In our study, vitamin C supplemen-
tation has increased the t-SH levels in femur bone tissue
and in plasma, but this increase is not statistically
significant and further studies will make us understand
the role of t-SH in OP.
Vitamin C is an influential antioxidant that decreases
the effects of free radicals. It limits antioxidants’ bone
resorption. Other mechanisms in which vitamin C assists
BMD are still not clear, but it is known that it takes place
in collagen formation growth of osteoblasts or increase in
Ca absorption (35).
In various studies, it was shown that, in postmenopau-
sal females there is a relationship between dietary vitamin
C intake and BMD (36). Hall and Greendale (36) showed
a consistent positive association of vitamin C with BMD
in postmenopausal women with dietary calcium intake of
at least 500 mg. Ilich et al. (37) in a cross-sectional study
showed significant relationship between BMD and sev-
eral critical nutrients such as: energy, protein, calcium,
magnesium, zinc, and vitamin C. It was shown that
people who smoke and take low doses of vitamin C and E
in their diets have a higher incidence of hip fracture. It
was shown that vitamin C and niacin intake in post-
menopausal females and iron and zinc intake in pre-
menopausal females are related closely with the forearm
bone mineral content. On the other hand, Wolf et al. (12)
did not find any correlation between vitamin C and
BMD, but with hormone therapy they found a relation.
They also found that in females with high total vitamin C
concentration it plays a good role.
Vitamin C deficiency is known in rats and pigs (38),
and when they are feeded with low levels of ascorbate
many deformities have been pointed out: shortness in the
legs, multiple fractures, OP, growth retardation, and
tendencies to haemoragies.
Melhus et al. (39) investigated the potential role of
antioxidating vitamin on the hip fractures in people who
smoke. They reported that if vitamin C and E are taken in
low quantities, besides other factors such as age, weight,
and other OP risk factors, they cause as much as five
times more hip fractures. They concluded that sufficient
vitamins intake could protect people from the side effects
of smoking.
Morton et al. (13) studied 994 postmenopausal women,
in which 277 of them were regularly taking vitamin C
support. Daily intake of vitamin C was 1005,000
(average 745 mg) and the average of the year of intake
was 12.4; 85% of them reported that they were taking
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can say that vitamin C intake has beneficial effects in
BMD, especially if they are combined with hormone
therapy. In this study, optimal doses were not determined.
But best results (high BMD level) were by obtained/
taking 1,000 mg/day or higher.
Simon and Hudes (40) showed a linear relationship
between ascorbic acid intake with diet and BMD
in premenopausal women. A relationship was found
between decreased spontaneous fractures and ascorbic
acid levels in females who took estrogen and smoke, but
surprisingly they reported a correlation in females who
do not use estrogen or smoke.
Maggio et al. (7) pronounced that in elderly osteo-
porotic patients, there is a significant decrease in vitamin
levels, SOD, and GPx activity. They also reported that
taking vitamin C and E with diet is protective against hip
fractures. Wolf et al. (12) in a cohort study indicated a
correlation between dietary antioxidant intake, to total
intake serum concentrations and BMD.
With all these results, decreasing on bone resorption
and on BMD, vitamin C plays an important role. Further
studies need to be done on this subject.
In our study, we added 1 g vitamin C (L-ascorbic acid)
to 500 ml of water. We changed the water every day and
vitamin C was administered (as explained earlier) as rats
consumed 1012 ml (ml/100 g/day) water every day (41).
In this case, our rats took 5075 g of vitamin C every day.
In our study, BMD was totally restored and OS was
prevented in female rats.
In our study we did not measure the vitamin C level.
On the other hand, Li and Schellhorn (42) indicated that
understanding the effect of vitamin C on various illnesses,
serum vitamin C level along with serum glucose level
must be measured. It is pointed that hormones and
glucose levels affect the process of measuring serum
vitamin C level.
For the aforementioned reasons, vitamin C level must
specially be measured in studies on humans. In diabetes,
blood sugar must be controlled in hyperglycemic states
and vitamin C must be increased.
Wronski et al. (3) characterized the bone deficiencies in
rats with postmenopausal or ovarian deficiency in 12
control and 12 ovariectomized rats (90 days old) in a
18-month period. They observed that in 6-month-old rats
cancellous bone volume were almost stable and reduced
later. In contrast to this, in ovariectomized rats the
proximal tibia bone volume was dramatically lost in 2
weeks and in 100 days callose bone volume was 57% and
on day 270 bone volume was 12%. In ovariectomized
rats, osteoblast level, osteoclast level, and bone formation
were higher compared with control group (especially in
100 days in ovariectomized rats) As a result, they said
ovariectomy in mature rats causes a rapid bone loss in
conjunction with maximum increase in bone circle.
For that reason we used mature rats (100 days old)
in our study. After this period we also found that there
was a statically significant reduction in BMD.
Our study has some limitations. First, the number of
rats used is not sufficient. Because of this, a relationship
between BMD and oxidant parameters could not be
found. If the study was done with large number of
animals, we could have been more successful. On the
other hand, vitamin C level intake and output liquid were
not measured in our study, and these were our limita-
tions.
To conclude, our results suggest that ovariectomy may
produce OP and OS in females, and vitamin C supple-
mentation may provide alterations regarding improve-
ment in OS and BMD values. We assume that studies
including more subjects are needed to make a decisive
conclusion about OSBMD relation.
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